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Obesity, a global epidemic of the modern era, is a risk factor for cardiovascular
diseases (CVD) and diabetes. The pervasiveness of obesity and overweight in both
developed as well as developing populations is on the rise and placing a huge burden
on health and economic resources. Consequently, research to control this emerging
epidemic is of utmost importance. Recently, host interactions with their resident gut
microbiota (GM) have been reported to be involved in the pathogenesis of many
metabolic diseases, including obesity, diabetes, and CVD. Around 1014 microorganisms
reside within the lower human intestine and many of these 1014 microorganisms have
developed mutualistic or commensal associations with the host and actively involved
in many physiological processes of the host. However, dysbiosis (altered gut microbial
composition) with other predisposing genetic and environmental factors, may contribute
to host metabolic disorders resulting in many ailments. Therefore, delineating the role
of GM as a contributing factor to obesity is the main objective of this review. Obesity
research, as a field is expanding rapidly due to major advances in nutrigenomics,
metabolomics, RNA silencing, epigenetics, and other disciplines that may result in the
emergence of new technologies and methods to better interpret causal relationships
between microbiota and obesity.
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INTRODUCTION
Pervasiveness of obesity and the other disorders associated to this, for example, metabolic
syndrome, have become a great challenge for health care throughout the world (Kovatcheva-
Datchary and Arora, 2013). Obesity is a multifaceted andmulti-factorial condition that results from
the interaction of one’s genotype with environmental exposures.
It was estimated by theWorldHealth Organization that 1.9 billion adult people were overweight,
out of which 600 millions were obese in 2014. Futhermore, recent estimates of 2014 indicate that,
since 1980, incidence of obesity has more than doubled (WHO, 2015). Globally, obesity is rising
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as an epidemic and is identified to be an emerging public health
threat in the Middle Eastern region (Lobstein et al., 2004). In
the United States, obesity and overweight individuals are prone
to premature mortality, possibly arising from multiple etiologies
(Fat et al., 1998) while in Canada, 57% of adult men and 35%
of adult women are overweight or obese (Canning et al., 2004).
Recent data reported that around 18.3% of the adult Canadian
population could be classified as obese (Twells et al., 2014).
Moreover, it was reported in 2007 that about 40% of adults in
Tehran were overweight and 23.1% of these individuals were
obese (Rezaeian and Salem, 2007). The problem is more severe in
most of the European countries. Data collected from European
countries claimed that around more than half of the European
population were obese or overweight (Eurostat, 2015). Latest
national data from the USA as of November 2015, on obesity
among adults and youth revealed that around 36% of adults and
17% percent of children and adolescents are obese (Ogden et al.,
2014).
Obesity has appeared as an endemic disorder that is
prominent in developed countries and is quickly emerging as a
major problem in some of the developing countries such as Saudi
Arabia.
For the past three decades, Saudi Arabia has experienced
considerable economic growth drastically impacting lifestyle of
citizens, specifically eating and exercise habits (Darwish et al.,
2014) giving rise to major nutritional changes among the Saudis
(Musaiger, 2011) leading to a higher prevalence of overweight
and obesity to alarming levels (Al-Nuaim et al., 1997). According
to the local news agency, around 70% of adult Saudis are obese or
overweight (Arab News, 2014).
A study conducted in 2012 indicated that percent body fat
among Saudi children and teenagers is rising and thus resulting
in an increase in obesity (Al-Hazzaa et al., 2012). The estimates
show that Saudi children and teenagers are 26.6 and 10.6%
overweight or obese, respectively (El Mouzan et al., 2010). Saudi
adolescents between the ages from 15 to 19 years were reported
to suffer from sleep deprivation and thus are exposed to high risk
of overweight and obesity (Al-Hazzaa et al., 2012).
Recently, the resident microbial communities, known as Gut
Microbiota (GM), has been suggested to be a major driving
force in the pathogenesis of metabolic disease and obesity, in
particular (Kovatcheva-Datchary and Arora, 2013; Khan et al.,
2014; Nguyen et al., 2015). Besides genetic, environmental, and
the immune system related factors, GM is one of the contributing
factor in developing obesity (Giovanni et al., 2010). Thus,
scientific interest has been directed toward understanding the
contributions of GM in obesity and metabolic disease. The GM
exerts their role through several integrated pathways including
the host immune system, responses to the environment including
diet and their genome in addition to several factors (Ferreira
et al., 2011; Khan et al., 2014).
Around 1014 microorganisms colonize various parts of the
human body and human body is estimated to be around 90%
bacterial cells of all cells (Khan et al., 2014). Generally, they
colonize exterior and interior mucosal surfaces of the human
body. Microbes colonizes skin, gastrointestinal, genitourinary,
and upper respiratory tracts as well as other sites on the
human body. They are found in high concentrations in the
lower gastrointestinal tract (Frank et al., 2007; Hattori and
Taylor, 2009). The GM are primarily bacterial though fungal,
protozoan, and archaeal species have been isolated too (Khan
et al., 2014). Furthermore, the collective metagenome content is
150-fold larger on a gene basis than that of the human genome.
Bacteria constitute 99% of the total GM, in which 90% fall under
two main phyla the Firmicutes and Bacteroidetes. However, a
small population of bacteria belongs to the phyla Proteobacteria,
Actinobacteria, Verrucomicrobia, and Fusobacteria (Khan et al.,
2014).
Humans have coevolved and thus developed several symbiotic
associations with their GM that accounts for the high
concentrations of GM. The GM association with their hosts could
be commensal (negligible net effect on host physiology) leading
to enhancing the overall ability of the body to be a better fit
for survival. It has been reported that GM plays an important
role in enhancing the digestion and absorption of otherwise
indigestible nutrients as well as energy turnover (Dethlefsen et al.,
2006; Round and Mazmanian, 2009; Foster and Neufeld, 2013).
GM diversity and composition are profoundly influenced by
host diet, lifestyle, and environmental factors (Maslowski and
Mackay, 2011; Graf et al., 2015). Advanced analytical platforms
such as metagenomics and metabolomics, revealed that GM
help host in harvesting energy and lead to increasing adiposity
(Dumas et al., 2006; Martin et al., 2008; Turnbaugh et al., 2008;
Turnbaugh and Gordon, 2009). Accordingly, a 20% increase
in Firmicutes and a corresponding decrease in Bacteroidetes
were found to be associated with the increase in energy intake,
thus inducing obesity (Rautava et al., 2012). GM population
surveys primarily are basedon clinical data, as well as data
obtained from gnotobiotic mice and epidemiological studies.
This includes studies conducted on various human populations
and risk groups such as formula vs. breastfed infants and
Cesarean- vs. vaginally delivered infants (Koenig et al., 2011;
Maynard et al., 2012). However, emerging research indicates that
modern dietary, hygienic, and medicinal practices strongly affect
the variations in GM composition. GM composition is involved
with a number of chronic diseases and ailments including obesity
among populations in the developed countries (Backhed et al.,
2004; Turnbaugh et al., 2006), diabetes (Ehehalt et al., 2010),
inflammatory and immune disorders (Penders et al., 2007), and
cancer (Zhang et al., 2012; Khan et al., 2014). This review
examines the contributing role of GM in the development of
obesity. Various factors are discussed that contribute to the
development of obesity.
DIET EFFECTS ON GM COMPOSITION
Despite multiple paths and physiological factors, obesity is
tightly linked to diet, and lifestyle that could promote several
other metabolic disorders if not properly managed (Kovatcheva-
Datchary and Arora, 2013; Boursier and Diehl, 2015). It is now
a fact that GM is playing important role in harvesting energy
efficiently from the diet (Khan et al., 2014; Graf et al., 2015). The
GM participates within various biochemical pathways to assist in
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digestion and metabolism of food. Interestingly, the GM of obese
individuals exhibits aberrant carbohydrate and lipids metabolism
(Rautava et al., 2012; Caesar et al., 2016). Recent studies showed
that the consumption of diet emulsifiers have been associated
with changes in the GM composition (Chassaing et al., 2015).
Carbohydrates are a vital source of dietary energy. However,
humans are not capable of digesting all linkages inherent to
oligo- or polysaccharides. Non-digestible carbohydrates include
plant-derived fibers such as xylans, cellulose, inulin, and resistant
starch. GM degrades these carbohydrates for harvesting energy
and providing the host with a variety of metabolites such as
short-chain fatty acids (SCFAs) propionate, acetate, and butyrate
(Tremaroli and Bäckhed, 2012). These SCFAs affect glucose,
cholesterol, and lipid metabolism in different body tissues (den
Besten et al., 2013). Polysaccharide fermentation by GM impacts
host adiposity through modulating energy derived from dietary
substrates (Tremaroli and Bäckhed, 2012).
The type of food intake by the human host influences the
GM composition and diversity (Carmody et al., 2015; Gérard,
2016). For instance, the western diet (high fat) results in
a reduction of Bacteroidetes and an increase in Firmicutes,
especiallyMollicutes (DiBaise et al., 2012). The latter is associated
with an enrichment genes involved in carbohydrate catabolism
(Turnbaugh et al., 2008; Bested et al., 2013). Accordingly,
obese individuals are known to have a microbiota rich in
Firmicutes and lower in Bacteroidetes as compared to the GM
of lean individuals (Scott et al., 2015). Similarly, Prevotellaceae,
a hydrogen-producing bacteria, and archaeal species were
abundant in obese individuals. It was demonstrated that the
transfer of hydrogen between archaeal and bacterial species
might enhance energy harvest efficiency within the gut (DiBaise
et al., 2012; Doré and Blottière, 2015). Interestingly, high-fat diets
modulate the microbiome composition to increase circulatory
lipopolysaccharides coinciding with general inflammation (Cani
and VanHul, 2015). General dysbiosis within the gut is associated
with a high level of plasma endotoxin and inflammation that
eventually promotes metabolic disorder (Zhang et al., 2010,
2013). Zhang et al. (2013) showed that one of the endotoxins
producing bacteria (i.e., Enterobacter), when inoculated into
germ-free mice resulted in the induction of obesity and insulin
resistance (Zhang et al., 2010). Moreover, the host genetics, diet,
and different environmental factors influence the etiology of
liver disorders. As such, the GM has been recognized as being
important in greatly influencing the host metabolism. GM may
have a double-edged sword and may exert both beneficial and
deleterious extra-intestinal influence to the host.
Furthermore, GM actively participate in bile acid (BA)
activation, metabolism, and regulation (Sayin et al., 2013).
BA is secreated from liver to digestive system and help in
lipid absorption (Inagaki et al., 2005; Kuribayashi et al., 2012).
Abnormal BA level has been linked with various metabolic
diseases including obesity (Kuribayashi et al., 2012). Gut bacteria,
especiallyClostridium scindens, Clostridium sordellii, and Bacillus
fragilis have a proven role in the biotransformation of BA
(Miyata et al., 2009). Any aberration in GM composition can
modulate BA level and can accordingly manipulate obesity
(Ridlon et al., 2014). However, theantimicrobial activity of
conjugated-BAs is suppressed during deconjugation through
the bile salt hydrolase enzyme, which is excreated by the GM,
especially bacteria from the phyla Firmicutes, Bacteroidetes, and
Actinobacteria.
GM MODULATE ENERGY INTAKE
Obesity is a consequence of a prolonged imbalance between
energy intake and expenditure caused by a complexinterplay
between genetic susceptibility and nutritional, physiological,
social, and environmental factors (Brahe et al., 2016). In
addition, it has been estimated that 40% of the gut microbial gene
pool is shared among individuals (Qin et al., 2010), and there
seems to exist a core microbiome, which is a set of microbial
genes shared among the vast majority of healthy individuals
that enables conservation of several important functional
pathways including those involved in energy metabolism
(Brahe et al., 2016). The connection between GM and energy
homeostasis and inflammation and its role in the pathogenesis
of obesity-related disorders are becoming increasingly
recognized.
Mammalian evolution includes innovation of mechanisms to
store energy in the form of adipose tissue for when needed
and providing physical protection during exercise (Chaput
et al., 2010). Maintaining energy homeostasis requires strict
regulation of energy intake and the amount consumed. Obesity
has increased in developed countries, in part, due to lifestyle
changes and the availability of energy high caloric foods. A
significant change in GM composition has been reported to
be associated with obesity. In addition, germ-free mice do not
develop diet-induced obesity. Such a finding indicates that the
effect of GM on the host metabolism and obesity induction is
achieved bymore efficient harvest of energy yield from consumed
food and modulating dietary or the host-derived compounds
that alter the host’s metabolic pathways (Tremaroli and Bäckhed,
2012; Graf et al., 2015).
No significant increase in weight was observed when germ-
free mice were fed a high-fat diet, intestinal SCFAs were reduced,
and calories were lost through urine and fecal elimination (Brun
et al., 2007; DiBaise et al., 2012).
It has been clearly demonstrated in animal models that GM
play a role in inducing obesity through a more efficient way for
better energy yield from consumed foods and by modulating
dietary or the host-derived compounds that alter host metabolic
pathway (Tremaroli and Bäckhed, 2012; Table 1). The same
results were observed after a patient had a Roux-en-Y gastric
bypass operation, where there was an increase in the presence of
Prevotella and Bacteroides which correlated in a negative manner
with energy intake and adiposity (Kovatcheva-Datchary and
Arora, 2013). Accordingly, The increased ratio of Bacteroidetes
to Firmicutes was linked with diminished body mass (De
Filippo et al., 2010; Kovatcheva-Datchary and Arora, 2013).
There are several Firmicutes genera/species typically isolated or
observed in the gut. This includes various genera associated
with Clostridia class (e.g., Ruminococcus) that may secrete
butyrate. In general, the primary Bacteroidetes genera associated
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TABLE 1 | List of some bacterial taxa and their association with obesity.
Bacterial taxa Association with obesity References
Firmicutes Associated with genes involved in carbohydrate catabolism and rich in
obese individuals. It was dominated the GM of European children. After
gastric bypass surgery Firmicutes level got decreased.
Turnbaugh et al., 2009; DiBaise et al.,
2012; Bested et al., 2013
Enterobacter An endotoxin producing bacteria which inoculated into germ-free mice
resulted in the induction of obesity and insulin resistance.
Zhang et al., 2015
Bacteroidetes (mainly include Bacteroides spp.
and Prevotella)
Is linked with diminished body mass. It dominated the microbiota of
children from rural African villages. It got enriched in the GM of mice
consuming a high fiberdiet as they are efficient utilizers of plant
polysaccharides.
De Filippo et al., 2010;
Kovatcheva-Datchary and Arora,
2013
Prevotella and Bacteroides Augmented with reduce adiposity in patients who received gastric
bypass operation.
Yatsunenko et al., 2012;
Kovatcheva-Datchary and Arora,
2013
Lactobacillusrhamnosus PL60 Conjugated linoleic acid (CLA-probiotic bacteria) and maintains the
body weight of mice fed a high fat diet.
Kovatcheva-Datchary and Arora,
2013
Escherichia coli Linked to the absence of obesity. Million et al., 2013a
Lactobacillus reuteri Positively linked with obesity and after using ready-to-use therapeutic
food containing this bacterium the weight gain was observed in
children suffering from Kwashiorkor disease.
Million et al., 2013b
Faecalibateriumprausnitzii Negatively associated with inflammatory markers that can alleviate
obesity.
Tremaroli and Bäckhed, 2012
Bacteroides thetaiotaomicron Capable of degrading dietary polysaccharides and fermenting fructans
to acetate that further promotes adipogenesis in mice.
Conterno et al., 2011
Prevotellaceae Hydrogen-producing bacteria, and archaeal species were abundant in
obese individuals.
DiBaise et al., 2012; Doré and
Blottière, 2015
It was demonstrated that the transfer of hydrogen between archaeal
and bacterial species may enhance energy harvest efficiency within the
gut.
Staphylococcus aureus Its presence in pregnant woman may increase the risk of obesity in
their progeny due to vertical transfer of bacterial populations during
birth or rearing.
Vaughan et al., 2002; Kalliomäki
et al., 2008
Bifidobacteria Dietary oligosaccharides derived from plant and milk stimulates the
growth of this bacteria.
LoCascio et al., 2007; Meyer and
Stasse-Wolthuis, 2009
Bifidobacterium spp. and Bacteroidetes Decrease in obese pregnant women. Santacruz et al., 2010
Prevotellaceae Increase in obese pregnant women. Santacruz et al., 2010
Firmicutes/Bacteroidetes Ratio was high in obese individuals compared to healthy subject. Santacruz et al., 2010
Methanobrevibacter smithii Associated with weight gain in children. Mbakwa et al., 2015
Bifidobacteriumanimalis and Lactobacillus
reuteri
Former was linked with normal weight gain and was found in low
concentration in obese individuals but the latter was reportedly
increased in obese patients.
Million et al., 2012
Weissellakoreensis Bacterial specie that is abundantly found in Kimchi and showed
anti-obese effect via production of ornithine.
Kang et al., 2013
(Continued)
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TABLE 1 | Continued
Bacterial taxa Association with obesity References
Lactobacillus gasseri SBT2055 (LG2055) The administration of this bacterium to HFD-induced obese male mice
prevents the gain of body weight by suppressing the expression of the CC
chemokine ligand 2 (Ccl2) gene in the adipose tissue of obese mice.
Ukibe et al., 2015
Staphylococcus aureus High statistical association between body mass index (BMI) and
Staphylococcus aureusws observed in female prisoners.
Befus et al., 2015
Lactobacillus casei CRL 431 The administration of this bacterium to diet-induced obese mouse led to
lowering of weight gain.
Nunez et al., 2014
Lactobacillus paracasei CNCM I-4270 and
Lactobacillus rhamnosus I-3690
Attenuate weight gain in high fat diet (HFD)-induced obese mice. Wang et al., 2015
Lactobacillus rhamnosus CGMCC1.3724 Supplementation of this bacterium to obese women helps achieve
sustainable weight loss.
Sanchez et al., 2014
Lactobacillus plantarum LG42 Showed anti-obese effect when administered to high fat diet (HFD)-induced
obese mice.
Park et al., 2013
Bifidobacterium breve B-3 Lowers body weight in diet induced obese mouse. Kondo et al., 2013
Lactobacillus curvatus HY7601 and
Lactobacilllus plantarum KY1032
Reduced body weight of diet-induced obese mice. Park et al., 2013
Lactobacillus gasseri BNR17 Showed anti-obese effect. Kang et al., 2013
Akkermansia muciniphila Showed inverse relation with obesity in human and diet-induced obese
mice.
Roopchand et al., 2015;
Schneeberger et al., 2015
with the gut are Bacteroides spp. and Prevotella. The same
results were observed when a patient received a gastric bypass
operation with Prevotella and Bacteroides were augmented
with reducing adiposity (Yatsunenko et al., 2012; Kovatcheva-
Datchary and Arora, 2013). There is, however, disagreement in
the scientific literature (Schwiertz et al., 2010). The role of GM
composition in relation to obesity is not clear. This is because
there are different etiological factors that are behind obesity and
can be linked to different microbes (Tremaroli and Bäckhed,
2012).
Conjugated linoleic acid (CLA) is a derivative of linoleic acid
that is naturally found in dairy products and has been involved
in increasing the metabolic rate in mice (West et al., 1998;
Kovatcheva-Datchary and Arora, 2013). The CLA-producing
probiotic bacteria (Lactobacillus rhamnosus PL60) maintain
the body weight of mice fed a high-fat diet. The same diet
had resulted in induction of obesity in mice that were not
colonized with either L. rhamnosus or Lactobacillus plantarum
(Kovatcheva-Datchary and Arora, 2013). Similarly, Escherichia
coli were linked to the absence of obesity (Million et al.,
2013b). In contrast, there are bacteria that have a positive
linkage to obesity, such as Lactobacillus reuteri and were linked
to weight gain in children affected with Kwashiorkor using
ready-to-use therapeutic food (Million et al., 2013a). Moreover,
certain strains like Faecalibaterium prausnitzii which are less
abundant in obese and diabetic patients may modulate obesity
through different mechanisms which are negatively correlated
with inflammatory markers proving that that F. prausnitzii may
lead to the modulation of obesity (Tremaroli and Bäckhed,
2012).
GM has the potential to synthesize a vast amount of enzymes
like glycoside which hydrolyses the breakdown of complex
plant polysaccharides to monosaccharides. This is in addition
to the production of ligands made of short-chain fatty acids
like acetate, propionate, and butyrate. When these ligands for
two G-proteins-coupled receptors Gpr41 and Gpr43, of gut
enteroendocrine cells bind, they result in the stimulation of
the gut peptide PYY which inhibits gut motility and slows
intestinal transit and it allow the better absorption of nutrients
and may be used as a treatment for obesity (Batterham et al.,
2003).
OBESITY CAN BE REGULATED BY
MODULATING GM
The hypothesis that obesity could be controlled by guiding the
composition and function of GM holds much potential for
therapeutic interventions (Burcelin et al., 2015; Wang et al.,
2015). For example, Bacteroides thetaiotaomicron is capable of
degrading dietary polysaccharides and fermenting fructans to
acetate that promotes adipogenesis in mice (Conterno et al.,
2011). In addition, the co-colonization of B. thetaiotaomicron
with other fermentable strains such as Methanobrevibacter
smithii can potentiate the process of adipose tissue build-up and
thus potentiates obesity (DiBaise et al., 2012).
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In order to control obesity in relation to the GM composition,
certain ecological and functional parameters remain to be
fully elucidated (Cani and Van Hul, 2015; Brahe et al.,
2016). Investigations into the ecological role of specific and
individual microbiota populations will likely yield targets for
probiotic interventions in communities that are incorrectly
assembled (Carding et al., 2015). There are several probiotic
strategies that have been developed containing Lactobacillus
acidophilus tailored toward reducing the serum cholesterol levels
in humans (Parvez et al., 2006; Cani and Van Hul, 2015).
Interestingly, in a study to characterize possible determinants for
childhood obesity, it was found that the common skin bacterium
Staphylococcus aureus in feces was a marker for obesity risk
during development (DiBaise et al., 2012). In a similar study
of pregnant women, overweight individuals harbored higher
concentrations of S. aureus. This may increase the risk of obesity
in their progeny due to a vertical transfer of bacterial populations
during birth or rearing (Vaughan et al., 2002; Kalliomäki et al.,
2008).
Based on animal studies, it was reported that the G-
protein-coupled receptor (GPR) deficient mice were abundantly
colonized by two commensals bacteria i.e., B. thetaiotaomicron
and M. smithii. Those mice were significantly leaner than their
wild-type counterpart littermates. This is possibly because Gpr
deficient mice had a lower expression of peptide tyrosine tyrosine
(PYY), fast intestinal rate, and reduced energy intake from
the consumed food. There was an increase in the glucagon-
like peptide (GLP)-1 as a response to GM fermentation of
prebiotics, which promoted L-cell differentiation in the rat’s
colon. The treatment of ob/ob mice with prebiotic crbohydrates
has resulted in the alteration of the GM composition and an
increase in the circulating GLP-1 and GLP-2. The GLP-1 was
important in mediating the prebiotic action and prevented
its effects on body weight gain, glucose metabolism, and
inflammatory pathway activation. Studies showed that GLP-
2, a 33-amino acid peptide, may cause the GM to modulate
the gut barrier and endotoxinemia and is known for its
intestinotrophic properties (Samuel et al., 2008; De Silva and
Bloom, 2012).
The presence of Akkermansia mucin I Phila is associated
with a more efficient glucose metabolism and leanness in mice.
However, this has not yet been proven in humans. The new
findings indicate that the higher abundance of A. mucin I
Phila results in healthier metabolic status in overweight/obese
humans and is associated with improved glucose homeostasis,
blood lipids, and body composition after calorie restriction. The
current data need to be investigated further to allow for a more
conclusive link to ascertain the therapeutic applicability of A.
muciniphila in the treatment of insulin resistance. In addition to
the possible use of A. muciniphila as a diagnostic or prognostic
tool to predict the potential success of dietary interventions (Dao
et al., 2016). Obesity is likely to be related to: (a) an increase in
Firmicutes phylum, (b) a reduced abundance of Bacteroidetes, (c)
a higher level of Actinobacteria phylum, (d) a Lower proportion
of Verrucomicrobia, and (e) a reduction in the abundance of
Faecalibacterium prausnitzii spec. (Chakraborti, 2015).
RELATIONSHIP BETWEEN GM AND
OBESITY
There are several well-established risk factors for obesity
including genetics, lifestyle, and dietary habits. However,
recently, and due to new advances in nucleic acid sequencing
technology, there has been an emerging field to examine GM’s
role in obesity. Fecal transplantation studies conducted on mice,
humans, and human-to-mouse have led to several molecular
links between GM composition and obesity (Conterno et al.,
2011). It has been reported that a healthy woman (BMI 26)
who had contracted a reoccurring Clostridium difficile infection
undergone fecal transplant from her overweight yet healthy
daughter became obese (BMI 34.5) 36 months after receiving the
fecal transplant. The mother failed to lose weight after following
a “medically supervised liquid protein diet and exercise program”
(Brandt, 2012; Alang and Kelly, 2015).
Inter-individual variation in microbiome composition and
methodological tools has led to some difficulties in reconciling
large taxonomic surveys of healthy or obese associated
microbiota. This includes impactful studies conducted by the
Human Microbiome Project and the Metagenomics of the
Human Intestinal Tract (MetaHIT). Thus, a scientific consensus
on what constitutes a conserved obese enterotype is not fully
realized.
In obese patients, a bimodal distribution of microbial gene
richness has been noted. Obese individuals are stratified as
either having high Gene Count (HGC) or Low Gene Count
(LGC). A high prevalence of presumed anti-inflammatory
species of F. prausnitzii was noted in 32 HGC individuals with
higher production potential of like butyrate as well as other
organic acids. A different pattern was seen in LGC individuals
who demonstrated a higher relative abundance of potentially
proinflamatory Bacteroides spp. and genes associated with
oxidative stress response. A significant association of biochemical
obesity-associated variables, such as insulin resistance, was
observed with gene counts. However, weight and BMI did not
show such an association. Such a phenomenon underscores
the inadequacy of using BMI as an indicator of “Obesity and
its Associated Metabolic Disorders” (OAMD). Later it was
shown that in a diet used for the induction of weight-loss
significantly resulted in higher gene richness in individuals with
LGC associated with improved metabolic status. Although gene
richness was not fully restored, the data further support the
reported link between GM structure and the long-term dietary
habits. Based on that, it was concluded that diet can play a crucial
role in the permanent adjustment of the microbiota (Marchesi
et al., 2016).
It was published that GM-promoted storage of circulating
triglycerides into adipocytes. Such an activity was caused by
suppressing the intestinal secretions of an inhibitor of adipose
tissue lipoprotein lipase FIAF, which is angiopoietin-like protein.
Consistently, in FIAF-deficient knockout (KO) mice, only a 10%
increase in total body fat was observed(Giovanni et al., 2010).
This is in comparison to a 57% fat gain noted in wild-type
littermates. Experiments on germ-free FIAF KO mice fed with a
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high fat, containing high-carbohydrate levels were not protected
from diet-induced obesity. Consequently, the blunted FIAF
expression might have led to the accumulation of triglyceride in
adipocytes and adipose tissue hypertrophy of conventionalized
germ-free mice (Giovanni et al., 2010).
It is well-established that environmental factors including
host diet influence the relative representation of certain bacterial
phyla in the gut. Beyond population structure, it is clear that
functional attributes of a community may drastically influence
host metabolism (Martin and Sela, 2013). Nutrition influences
the composition of the gut microbiome such as high fiber food
that passes to the colon (Khan et al., 2014; Song et al., 2016).
For this reason, studies showed more diversified levels of GM
in rats reared on high fiber diets (Blaut and Klaus, 2012).
Fermentable fibers are utilized by specific microbiota capable of
metabolizing the molecular structure of a given substrate. As
an example, dietary oligosaccharides including plant and milk-
derived stimulate the growth of Bifidobacteria (LoCascio et al.,
2007; Meyer and Stasse-Wolthuis, 2009). Mouse studies confirm
this, as the GM shifts when standard chow is changed to a semi-
synthetic high-fat diet due to a lower percentage of fermentable
dietary fibers (Fleissner et al., 2010).
There are several disparities regarding the relative ratio
of Firmicutes/Bacteroidetes in obese individuals compared to
healthy subjects (Santacruz et al., 2010). Interestingly studies
conducted in developed countries, higher ratios of Firmicutes
to Bacteroidetes have been linked to obesity. In a comparative
study, Bacteroidetes dominated the microbiota of children from
rural African villages, while Firmicutes dominated themicrobiota
of European children (De Filippo et al., 2010). Differential GM
composition was attributed to diet as well as ethnicity, sanitation,
hygiene, geography, and/or climate (De Filippo et al., 2010).
Bacteroidetes dominated the microbiota of children from rural
African villages while Firmicutes dominated the microbiota of
European children. Differential GM composition was attributed
to diet as well as ethnicity, sanitation, hygiene, geography, and/or
climate (De Filippo et al., 2010). Other studies did not identify
such a correlation and reported that the relative abundance
of Firmicutes decreased following gastric bypass surgery (De
Filippo et al., 2010). Moreover, obese pregnant women exhibited
a decrease in Bifidobacterium sp. and Bacteroidetes with an
increase in Prevotellaceae (Santacruz et al., 2010).
There have been attempts to define a “core microbiome” as
some have speculated that deviation from a core structure may
lead to pathologies such as obesity (Turnbaugh et al., 2009;
Kovatcheva-Datchary and Arora, 2013). Although a conserved
core microbiome structure is difficult to identify due to high
inter-individual variation (Qin et al., 2010), community function
may be conserved within this variation. It is noteworthy that
GM of obese individuals exhibit less taxonomic richness and
potentially diminished metabolic capacity than the microbiota of
lean individuals (Turnbaugh et al., 2009; Greenblum et al., 2012;
Kovatcheva-Datchary and Arora, 2013).
In studies of obese and lean twins, microbial groups were
found correspondingly enriched or depleted in the lean and
obese subjects (Turnbaugh et al., 2009). Most of the microbial
genes that were linked with obesogenic pathways did not belong
to Bacteroidetes but came from either Actinobacteria (75%) or
Firmicutes (25%). In a follow-up study conducted on mice, the
microbiome composition shifts in just 1 day after switching mice
from low fat (rich in fiber) to a high-fat diet with increased
adiposity occurring just 2 weeks (Turnbaugh et al., 2009).
Bacteroidetes were enriched in the GM inmice consuming a high
fiber diet, as they are efficient utilizers of plant polysaccharides
(Maslowski and Mackay, 2011). This is in contrast to the
Firmicute enrichment and associated obesogenic microbiota in
high caloric diets typically encountered in developed countries.
Future research should focus on assessing the possibility of
altering the Firmicutes to Bacteroidetes ratios as a therapeutic
solution to obesity. Such an alteration may be achieved by
the use of either antimicrobial agents (Morgun et al., 2015)
and/or the use of probiotics in conjunction with changing the
selective environment induced by switching to a low-fat/high-
fiber diet.
Aspects related to understanding the relationship between
GM in relation to Obesity:
There are still lots of pitfalls regarding the understanding
of the relationship between diet, lifestyle activities, GM, and
obesity. Most of the investigations concentrated on GM in the
gastrointestinal tract. However, other important aspects have
been overlooked and include the following (Conlon and Bird,
2014):
1. Better understanding of the functions of GM and their
physiological relevance to obesity.
2. Identification of the different types of genes of the current
GM and the many more newly discovered ones and
their function in breaking down of the different types of
foods, their role in energy harvest and the resulting by-
product(s)in relation to obesity.
3. Focus should also be made on understanding the role of
bacteria in the small intestine (ileum and cecum) and the
role of diet in the overall health of the small intestine,
which may become inflamed because of imbalances in
gut microbial populations in addition to delineating the
involvement of bacteria in the small intestine enteropathies,
leaky gut, and obesity.
4. Understanding the influence of the different types of foods
that have the ability to compromise the integrity of the gut
mucosa, which is considered of critical importance to the
overall health and to obesity. Diets should be tailored toward
foods that keep the gut mucosa intact and prevent invading
microbes from causing inflammation in the gut mucosa.
5. Delineating the association between GM and immune
system; such an understanding will reveal how GM can
contribute to obesity or not and such an information can
be used to design diets to promote optimal body weight.
6. Understanding the bidirectional communication of data
between GM on the satiety center in the brain and their
effect on obesity.
7. Effect of dietary manipulation affects GM composition
among individuals and their effects on mode swings and
food intake and their consequences on obesity.
8. Food by-products effect on GM and in turn on obesity.
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9. Understanding the inter-individual variations of GM and
their role in obesity.
10. The modulation of the microbial profile based on the
understanding the origins and variations to fight obesity.
11. Understanding the genetic predisposition to obesity and
how environmental factors and diet can be modified to
overcome this problem. This may result in the development
of diets with an optimum composition to enhance the
growth of certain bacteria that will counteract the effect of
the genetic factors of the host that can better resist obesity.
12. The effect of long-term dietary habits on the microbial
populations in the GM.
13. Effect of long-term administration of vitamins, amino acids,
and micronutrients including phytobiologics on the GM
composition and their consequences on obesity.
14. Understand how the main constituents of the diet affect GM
composition and their effect on obesity.
15. The effect of food matrix, structure, the particle size, and
the interaction of the food matrix with the gastric enzymes
found in the gut.
16. The influence of cooking food or consuming it raw and its
effects on GM and its relation to obesity.
17. The effects of prebiotics and probiotics on the GM and their
relationship to obesity.
The role of GM may contribute to the increased incidence of
autoimmune and metabolic diseases in developed countries. An
example is Type-1 and type-2 diabetes. Understanding the role
that GM plays in these two diseases may result in prevention and
intervention strategies to control those two diseases. However,
well-controlled prospective human studies are required for the
understanding of the role of the GM and its response to
environmental factors in order to identify effective preventive
strategies targeting specific component of the gut ecosystem
(Nobel et al., 2015).
CONCLUSION
During the last decade or two, there has been an exponential
increase due to “omics” technologies in our understanding of
the composition and functions of the human GM. The “omics”
technologies have made it easier to analyzed on a large large-scale
of the genetic and metabolic profile of microbial communities,
thus offering the possibility of a new route for therapeutic
intervention. Their association is similar to what has been seen
in the immune system, which comprises a collection of cells
that work in harmony either with the host in order to promote
health or in other instances cause disease. Obesity is a major
problem worldwide and any possible was should be used to
control it. Scientists worldwide are trying to use different and
latest technologies to treat obesity. It well-documented that there
are different factors that contribute to obesity other than the
increased energy harvest from the diet. It is extremely necessary
to decipher the underlying association between the adipose tissue
and pathophysiology in relation to different metabolic disorders
including but not only limited to obesity (DiBaise et al., 2012;
Pekkala et al., 2015).
As such, different mechanisms have been proposed to link to
the composition. This field is still is in its early stages and require
elaborately controlled studies to substantiate the available data
that link obesity to GM. Based on the above, it is evident that
better understanding of the role of GM in obesity would lead to
possible solutions tomanage this disorder. The GM compositions
are genetically predisposed and are affected by the type of diet
consumed and its role in the treatment of obesity should not
be overlooked. Future work should be conducted in a very
controlled manner to have a reproducible data that will delineate
the role of microbiota in obesity across the globe. For this reason,
there is an urgent need for an open and enhanced dialogue
between experimental scientists and computational scientists to
uncover possible reasons behind the conflicting results that are
published and to: get novel findings in the field, synthesize diverse
information related to GM and obesity and accelerate the future
of discovering new therapeutic applications.
Finally, it would be of interest to identify different bacterial
phyla that are involved with obesity and treatment of obesity can
be achieved via the modification of the microbiota of the obese
persons. Such a process may be achieved by transplantation of
known microbiota that are not involved in obesity.
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